Published in mSphere on January 18, 2017
A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids. R Soc Open Sci (2017) 0.77
Nanostructured delivery systems with improved leishmanicidal activity: a critical review. Int J Nanomedicine (2017) 0.75
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet (2007) 4.58
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature (2014) 3.15
Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol (2014) 2.65
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife (2014) 2.65
Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proc Natl Acad Sci U S A (1997) 2.53
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res (2011) 2.21
Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science (2015) 2.07
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res (2011) 1.90
CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods (2015) 1.88
Scalable and versatile genome editing using linear DNAs with microhomology to Cas9 Sites in Caenorhabditis elegans. Genetics (2014) 1.61
Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9. MBio (2014) 1.61
A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans. Genetics (2014) 1.60
Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. Mol Cell Biol (1994) 1.57
Sequence determinants of improved CRISPR sgRNA design. Genome Res (2015) 1.56
Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani. Mol Biochem Parasitol (1996) 1.52
A role for RAD51 and homologous recombination in Trypanosoma brucei antigenic variation. Genes Dev (1999) 1.51
Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat Commun (2014) 1.48
Glucosylated hydroxymethyluracil, DNA base J, prevents transcriptional readthrough in Leishmania. Cell (2012) 1.46
Epidemiology of visceral leishmaniasis. Clin Epidemiol (2014) 1.42
Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem (2003) 1.42
RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Res (2012) 1.36
Sequence homology and microhomology dominate chromosomal double-strand break repair in African trypanosomes. Nucleic Acids Res (2008) 1.32
Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum. Nat Methods (2014) 1.31
Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology. Cell Rep (2014) 1.30
Efficient chromosomal gene modification with CRISPR/cas9 and PCR-based homologous recombination donors in cultured Drosophila cells. Nucleic Acids Res (2014) 1.23
Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol Microbiol (2001) 1.21
CRISPR-Cas9-mediated single-gene and gene family disruption in Trypanosoma cruzi. MBio (2014) 1.17
The expression of biologically active human p53 in Leishmania cells: a novel eukaryotic system to produce recombinant proteins. Nucleic Acids Res (1995) 1.15
Alternative end-joining mechanisms: a historical perspective. Front Genet (2013) 1.13
Genomic organization and functional characterization of the Leishmania major Friedlin ribosomal RNA gene locus. Mol Biochem Parasitol (2001) 1.11
Inhibition of homologous recombination in human cells by targeting RAD51 recombinase. J Med Chem (2012) 1.10
Overview of DNA Repair in Trypanosoma cruzi, Trypanosoma brucei, and Leishmania major. J Nucleic Acids (2010) 1.01
Microhomology-mediated deletion and gene conversion in African trypanosomes. Nucleic Acids Res (2010) 1.01
Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasite Leishmania. PLoS Biol (2014) 0.96
Identification and characterisation of a RAD51 gene from Leishmania major. Mol Biochem Parasitol (2001) 0.94
CRISPR/Cas9-Induced Disruption of Paraflagellar Rod Protein 1 and 2 Genes in Trypanosoma cruzi Reveals Their Role in Flagellar Attachment. MBio (2015) 0.94
Characterization of the Leishmania donovani ribosomal RNA promoter. Mol Biochem Parasitol (1999) 0.94
Regulation of transcription termination by glucosylated hydroxymethyluracil, base J, in Leishmania major and Trypanosoma brucei. Nucleic Acids Res (2014) 0.93
Characterization of the Trypanosoma cruzi Rad51 gene and its role in recombination events associated with the parasite resistance to ionizing radiation. Mol Biochem Parasitol (2006) 0.92
MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems. Nat Protoc (2015) 0.90
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites. Cell Microbiol (2015) 0.90
A small molecule inhibitor of human RAD51 potentiates breast cancer cell killing by therapeutic agents in mouse xenografts. PLoS One (2014) 0.89
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani. MBio (2015) 0.88
Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain. PLoS Pathog (2014) 0.84
Enriching CRISPR-Cas9 targeted cells by co-targeting the HPRT gene. Nucleic Acids Res (2015) 0.83
Targeted Chromosomal Translocations and Essential Gene Knockout Using CRISPR/Cas9 Technology in Caenorhabditis elegans. Genetics (2015) 0.80
Deletion of an ATP-binding cassette protein subfamily C transporter in Leishmania donovani results in increased virulence. Mol Biochem Parasitol (2012) 0.77
Induction of site-specific chromosomal translocations in embryonic stem cells by CRISPR/Cas9. Sci Rep (2016) 0.77
Base J represses genes at the end of polycistronic gene clusters in Leishmania major by promoting RNAP II termination. Mol Microbiol (2016) 0.76
Development of a genetic assay to distinguish between Leishmania viannia species on the basis of isoenzyme differences. Clin Infect Dis (2006) 1.06
Screening Leishmania donovani-specific genes required for visceral infection. Mol Microbiol (2010) 0.96
Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review. PLoS Negl Trop Dis (2016) 0.89
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani. MBio (2015) 0.88
Entomological efficacy of durable wall lining with reduced wall surface coverage for strengthening visceral leishmaniasis vector control in Bangladesh, India and Nepal. BMC Infect Dis (2016) 0.81
One More Death from Visceral Leishmaniasis Has Gone by Unnoticed. What Can Be Done? PLoS Negl Trop Dis (2013) 0.80
Development of Leishmania vaccines in the era of visceral leishmaniasis elimination. Trans R Soc Trop Med Hyg (2015) 0.78
Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani. Eukaryot Cell (2012) 0.78
Investments in Research and Surveillance Are Needed to Go Beyond Elimination and Stop Transmission of Leishmania in the Indian Subcontinent. PLoS Negl Trop Dis (2017) 0.78
Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health. PLoS Negl Trop Dis (2017) 0.75